A two-sample Mendelian randomization study explores metabolic profiling of different glycemic traits

Area of Science:

• Metabolomics
• Genetic Epidemiology
• Endocrinology

Background:

• Glycemic traits and type 2 diabetes are linked to metabolic dysregulation.
• Understanding the causal relationships between glycemic control and metabolites is crucial for disease management.

Purpose of the Study:

• To investigate the causal relationships between four glycemic traits (fasting glucose, 2-h glucose, fasting insulin, glycated hemoglobin) and type 2 diabetes liability with 167 circulating metabolites.
• To differentiate between hyperglycemia-dependent and independent metabolic alterations in type 2 diabetes.

Main Methods:

• Utilized Mendelian randomization (MR) analysis with multiple sensitivity analyses.
• Employed reverse MR to assess potential reverse causality.
• Instrumental variables for glycemic traits and type 2 diabetes liability were derived from large-scale consortia and meta-analyses.
• Metabolite data were obtained from UK Biobank summary statistics.

Main Results:

• Fasting glucose and 2-h glucose showed no significant associations with any of the 167 metabolites.
• Elevated glycated hemoglobin was associated with increased levels of free cholesterol in small low-density lipoprotein particles.
• Type 2 diabetes liability and fasting insulin were inversely associated with apolipoprotein A1, total cholesterols, and lipoprotein subfractions (HDL, IDL), but positively associated with aromatic amino acids.

Conclusions:

• Findings suggest distinct metabolic patterns associated with glycated hemoglobin and type 2 diabetes liability/fasting insulin.
• The results highlight the significant role of insulin in type 2 diabetes pathogenesis, independent of hyperglycemia.
• Further research is warranted to explore the clinical utility of these glycemic traits in type 2 diabetes diagnosis and management.